Hologic UK has announced that it has received CE marking approval for its ThinPrep integrated imager, which was on display at the 35th European Congress of Cytology recently in Lisbon and shown for the first time in the UK at the IBMS Biomedical Science Congress in September. The integrated imager represents the latest innovation in cervical cancer screening by combining proven ThinPrep imaging technology and slide review into a single, convenient standalone device. This new product allows laboratories of all sizes to benefit from clinical advantages of ThinPrep imaging for cervical screening.
“This represents a tremendous opportunity for Hologic and our current and future laboratory partners throughout Europe,” said Howard Doran, senior vice president, diagnostics products for Hologic. “The ThinPrep integrated imager is designed to provide the small- and medium-volume laboratory access to the most effective and efficient cytology screening technology available, while allowing them to address their specific productivity and throughput needs.”
Hologic’s experience working with ThinPrep Pap test users contributed significantly to the integrated imager development. Every feature is designed to enable the cytotechnologist to perform slide review effectively and efficiently. The integrated imager can also be used as a conventional microscope.
CE marking approval allows Hologic to market the ThinPrep integrated imager in the 27 countries of the European Union and three of the four member states of the European Free Trade Association.
www.thinprep.com